Based in Silicon Valley, GRAIL has assembled a world-class team of leaders, scientists, clinicians, engineers, and other experts to develop new cancer detection technology based on advances in our understanding of the human genome and machine learning. This new detection technology can identify more than 50 cancers through a simple blood draw with a high degree of accuracy. Formed in January of 2016, GRAIL’s mission is to detect cancer early, when it can be cured.